Recent Quotes
My Watchlist
Indicators
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Akari Therapeutics (NQ: AKTX )

2.414 USD +0.024 (+1.00%)
Streaming Delayed Price Updated: 9:36 AM EDT, Apr 22, 2021 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 5,855
Open 2.440
Bid (Size) 2.410 (8)
Ask (Size) 2.430 (1)
Prev. Close 2.390
Today's Range 2.322 - 2.440
52wk Range 1.420 - 4.210
Shares Outstanding 3,847,331,923
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
Akari Therapeutics Announces Poster Presentation of Phase II Bullous Pemphigoid Disease and Phase III Trial Design at American Academy of Dermatology Association Virtual Meeting Experience
From GlobeNewswire News Releases
Akari Therapeutics Reports Full Year 2020 Financial Results and Highlights Recent Clinical Progress
From GlobeNewswire News Releases

Performance

YTD
+33.37%
+33.37%
1 Month
-18.17%
-18.17%
3 Month
-25.49%
-25.49%
6 Month
+48.10%
+48.10%
1 Year
+52.78%
+52.78%

More News

Read More
Akari Therapeutics Announces Initiation of Pivotal Phase III Trial of Nomacopan in Bullous Pemphigoid (BP)
From GlobeNewswire News Releases
Akari Therapeutics Announces a Cooperative Research and Development Agreement (CRADA) with the U.S. Army Institute of Surgical Research (USAISR) for Nomacopan in Trauma
From GlobeNewswire News Releases
Akari Therapeutics Presents New Preclinical Data Highlighting Potential of Long-Acting PASylated Nomacopan to Treat Retinal Diseases, Including Age-Related Macular Degeneration (AMD) and Uveitis
From GlobeNewswire News Releases
Akari Therapeutics Adds Histamine Inhibitor Votucalis to Pipeline to treat Neuropathic Pain and Dermatological Disease
From GlobeNewswire News Releases
12 Health Care Stocks Moving In Monday's After-Market Session
Tags Market News NOVN BZI/TFM
From Benzinga
Akari Therapeutics' To Go With Pivotal Bullous Pemphigoid Study With Nomacopan
Tags Phase 3 Trial New Drug Application News
From Benzinga
12 Health Care Stocks Moving In Friday's Pre-Market Session
Tags Benzinga EYES Movers
From Benzinga
12 Health Care Stocks Moving In Thursday's After-Market Session
Tags Market News FLGT EVFM
From Benzinga
Akari Therapeutics' PASylated Nomacopan Shows Promising Action In Animal Studies
Tags Benzinga Market News Health Care
From Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.